Session date: 
08/11/2016 - 6:00am to 7:00am

Learning Objectives:

Recognize the association of frailty to outcome in TAVR

To identify the economic implicains and value of TAVR

To understand the "genetic risk estimates" in guiding patient selection for TAVR.

Credit (if available) is announced on the Group Home page.  All sessions are reviewed individually and credit is pulled for any that doesnot meet the criteria.

Presenter: 
Shahyar M. Gharacholou, M.D.
Where did the idea for the course originate?: 
Florida
Please login or register to take this course.
Where did the idea for the course originate?: 
Florida